Cardiac resynchronisation therapy in 2015: Keeping up with the pace

A. Voskoboinik, A. D. Mcgavigan, J. A. Mariani

Research output: Contribution to journalReview ArticleResearchpeer-review

2 Citations (Scopus)


Despite improved understanding of the pathophysiology of heart failure (HF) and availability of better medical therapies, HF continues to grow as a cause of morbidity and mortality in Australia and worldwide. Over the past decade, cardiac resynchronisation therapy (CRT), or biventricular pacing, has been embraced as a powerful weapon against this growing epidemic. However, much has changed in our understanding of dyssynchrony in HF, and this has led to a change in guidelines to ensure more appropriate selection of CRT candidates to improve the 'non-response' rate. More data have also emerged about the use of CRT in atrial fibrillation and in pacemaker-dependent patients. There has also been a growing focus on multimodality imaging to guide patient selection and lead positioning. Exciting new lead technologies are also emerging, with the potential to improve CRT outcomes further.

Original languageEnglish
Pages (from-to)255-265
Number of pages11
JournalInternal Medicine Journal
Issue number3
Publication statusPublished - Mar 2016
Externally publishedYes


  • Biventricular pacing
  • Cardiac resynchronisation therapy
  • Dyssynchrony
  • Heart failure

Cite this